Sundrug Co.,Ltd.
SDGCF · OTC
Financial statements
Annual and quarterly income, balance-sheet, cash-flow and key-statistics data.
Income statement
| Period | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2023 FY | 690.46B | 1.29B | 37.45B | 25.70B | 219.83 |
| 2024 FY | 751.78B | 189.32B | 41.00B | 29.13B | 249.07 |
| 2025 FY | 801.81B | 204.09B | 44.50B | 30.75B | 262.91 |
| 2026 FY | 847.82B | 198.65B | 47.13B | 31.59B | 270.03 |
Balance sheet
| Period | Total assets | Liabilities | Cash | Debt | Equity |
|---|---|---|---|---|---|
| 2023 FY | 2.72B | 943.78M | 80.87B | 7.07M | 236.33B |
| 2024 FY | 420.21B | 167.12B | 69.70B | 35.00B | 253.09B |
| 2025 FY | 444.01B | 174.29B | 64.96B | 38.67B | 269.71B |
| 2026 FY | 478.50B | 190.69B | 70.97B | 48.52B | 287.80B |
Cash flow
| Period | Operating cash flow | Capital expenditure | Free cash flow | Dividends paid | Net cash change |
|---|---|---|---|---|---|
| 2023 FY | 281.36M | -196.55M | 84.81M | -10.05B | -125.12M |
| 2024 FY | 41.19B | -38.23B | 2.96B | -12.51B | -11.17B |
| 2025 FY | 41.16B | -34.27B | 6.90B | -14.27B | -4.74B |
| 2026 FY | 43.57B | -30.53B | 13.04B | -15.30B | 1.78B |
Key statistics
| Period | Market cap | Enterprise value | P/E | Price / sales | Debt / equity |
|---|---|---|---|---|---|
| 2023 FY | 378.66B | 297.80B | — | — | — |
| 2024 FY | 432.68B | 397.98B | — | — | — |
| 2025 FY | 494.24B | 467.95B | — | — | — |
| 2026 FY | 523.18B | 500.73B | — | — | — |
Income statement
| Period | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2026 Q1 | 207.70B | 53.34B | 12.28B | 7.94B | 67.92 |
| 2026 Q2 | 213.75B | 54.34B | 10.94B | 7.43B | 63.00 |
| 2026 Q3 | 217.46B | 56.08B | 13.49B | 8.97B | 76.86 |
| 2026 Q4 | 208.11B | 48.56B | 5.36B | 7.21B | 62.31 |
Balance sheet
| Period | Total assets | Liabilities | Cash | Debt | Equity |
|---|---|---|---|---|---|
| 2026 Q1 | 442.27B | 172.21B | 62.98B | 44.22B | 270.06B |
| 2026 Q2 | 450.62B | 173.16B | 66.14B | 43.62B | 277.46B |
| 2026 Q3 | 470.59B | 191.54B | 70.09B | 49.01B | 279.06B |
| 2026 Q4 | 478.50B | 190.69B | 70.97B | 48.52B | 287.80B |
Cash flow
| Period | Operating cash flow | Capital expenditure | Free cash flow | Dividends paid | Net cash change |
|---|---|---|---|---|---|
| 2026 Q1 | — | — | — | — | — |
| 2026 Q2 | — | — | — | — | — |
| 2026 Q3 | — | — | — | — | — |
| 2026 Q4 | — | — | — | — | — |
Key statistics
| Period | Market cap | Enterprise value | P/E | Price / sales | Debt / equity |
|---|---|---|---|---|---|
| 2026 Q1 | 474.56B | 455.80B | — | — | — |
| 2026 Q2 | 487.23B | 464.71B | — | — | — |
| 2026 Q3 | 517.08B | 496.00B | — | — | — |
| 2026 Q4 | 523.20B | 500.76B | — | — | — |